Evidence map›Paper›PMID 37340602›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Differential Protein and Glycan Packaging into Extracellular Vesicles in Response to 3D Gastric Cancer Cellular Organization.

Álvaro M Martins, Tânia M Lopes, Francisca Diniz, José Pires, Hugo Osório, Filipe Pinto, Daniela Freitas, Celso A Reis

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Álvaro M Martinsi3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.ORCID 0000-0003-0266-9093
Tânia M Lopesi3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.
Francisca Dinizi3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.
José Piresi3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.
Hugo Osórioi3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.
Filipe Pintoi3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.
Daniela Freitasi3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.ORCID 0000-0002-7606-1120
Celso A Reisi3S-Institute for Research and Innovation in Health, University of Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.ORCID 0000-0002-0286-6639
Universidade do Porto · PT

Funding

National Roadmap of Research Infrastructures of Strategic Relevance LISBOA-01-0145-FEDER-022125National Roadmap of Research Infrastructures of Strategic Relevance ROTEIRO/0028/2013Portugal Regional Operational Programme NORTE 2020Portuguese Foundation for Science and Technology (FCT) EXPL/BTM-ORG/1450/2021Portuguese Foundation for Science and Technology (FCT) EXPL/MED-ONC/1001/2021Portuguese Foundation for Science and Technology (FCT) PTDC/MEC-ONC/0491/2021stimulus of Scientific Employment, Individual Support 2020.04384.CEECIND
6 · The paper itself

Abstract

Alterations of the glycosylation machinery are common events in cancer, leading to the synthesis of aberrant glycan structures by tumor cells. Extracellular vesicles (EVs) play a modulatory role in cancer communication and progression, and interestingly, several tumor-associated glycans have already been identified in cancer EVs. Nevertheless, the impact of 3D tumor architecture in the selective packaging of cellular glycans into EVs has never been addressed. In this work, the capacity of gastric cancer cell lines with differential glycosylation is evaluated in producing and releasing EVs when cultured under conventional 2D monolayer or in 3D culture conditions. Furthermore, the proteomic content is identified and specific glycans are studied in the EVs produced by these cells, upon differential spatial organization. Here, it is observed that although the proteome of the analyzed EVs is mostly conserved, an EV differential packaging of specific proteins and glycans is found. In addition, protein-protein interaction and pathway analysis reveal individual signatures on the EVs released by 2D- and 3D-cultured cells, suggesting distinct biological functions. These protein signatures also show a correlation with clinical data. Overall, this data highlight the importance of tumor cellular architecture when assessing the cancer-EV cargo and its biological role.

Indexed as

Extracellular VesiclesStomach NeoplasmsCell LineHumansPolysaccharidesProteomicsPolysaccharidescancerextracellular vesiclesglycosylationlectinsproteome

Identifiers

PMID37340602
PMCPMC10460857
OpenAlexW4381470023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.